$ICDIQ
Independence Contract Drilling, Inc.

2023 Q4 Form 10-Q Financial Statement

#000153702823000041 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $45.83M $44.16M
YoY Change -23.94% -10.14%
Cost Of Revenue $31.47M $27.49M
YoY Change -12.46% -12.39%
Gross Profit $14.36M $16.67M
YoY Change -40.93% -6.18%
Gross Profit Margin 31.33% 37.75%
Selling, General & Admin $5.683M $6.865M
YoY Change -26.32% -2.03%
% of Gross Profit 39.58% 41.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.06M $10.23M
YoY Change 3.09% 1.09%
% of Gross Profit 77.0% 61.37%
Operating Expenses $17.32M $6.865M
YoY Change -6.04% -2.03%
Operating Profit -$2.965M $780.0K
YoY Change -150.5% 275.0%
Interest Expense -$9.763M -$9.222M
YoY Change 13.92% 13.88%
% of Operating Profit -1182.31%
Other Income/Expense, Net
YoY Change
Pretax Income -$26.88M -$8.442M
YoY Change 664.13% 7.0%
Income Tax -$931.0K -$844.0K
% Of Pretax Income
Net Earnings -$25.95M -$7.598M
YoY Change -849.81% 5.62%
Net Earnings / Revenue -56.62% -17.2%
Basic Earnings Per Share -$0.54
Diluted Earnings Per Share -$1.70 -$0.54
COMMON SHARES
Basic Shares Outstanding 14.08M 14.08M
Diluted Shares Outstanding 14.07M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.565M $6.000M
YoY Change 4.49% -20.7%
Cash & Equivalents $5.565M $6.044M
Short-Term Investments
Other Short-Term Assets $4.759M $1.900M
YoY Change 475800.0% 1762.75%
Inventory $1.557M $1.900M
Prepaid Expenses
Receivables $31.70M $26.87M
Other Receivables $0.00 $0.00
Total Short-Term Assets $43.58M $36.65M
YoY Change -15.66% -20.17%
LONG-TERM ASSETS
Property, Plant & Equipment $350.4M $368.7M
YoY Change -7.07% 0.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.908M $3.199M
YoY Change 48.37% 48.17%
Total Long-Term Assets $351.1M $369.5M
YoY Change -7.13% 0.58%
TOTAL ASSETS
Total Short-Term Assets $43.58M $36.65M
Total Long-Term Assets $351.1M $369.5M
Total Assets $394.7M $406.1M
YoY Change -8.15% -1.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.99M $17.28M
YoY Change -28.03% -40.14%
Accrued Expenses $16.37M $12.13M
YoY Change -7.03% -7.86%
Deferred Revenue $578.0K $434.0K
YoY Change -42.37% -64.63%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.226M $1.400M
YoY Change -50.66% -57.6%
Total Short-Term Liabilities $40.59M $30.81M
YoY Change -22.01% -32.21%
LONG-TERM LIABILITIES
Long-Term Debt $154.5M $156.3M
YoY Change 7.91% 14.29%
Other Long-Term Liabilities $8.201M $1.642M
YoY Change 9.73% -1.14%
Total Long-Term Liabilities $8.201M $1.642M
YoY Change 9.73% -1.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.59M $30.81M
Total Long-Term Liabilities $8.201M $1.642M
Total Liabilities $213.1M $199.7M
YoY Change -0.89% -1.77%
SHAREHOLDERS EQUITY
Retained Earnings -$436.8M -$410.8M
YoY Change 9.45% 2.06%
Common Stock $622.3M $621.2M
YoY Change 0.74% 0.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $181.6M $206.5M
YoY Change
Total Liabilities & Shareholders Equity $394.7M $406.1M
YoY Change -8.15% -1.72%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$25.95M -$7.598M
YoY Change -849.81% 5.62%
Depreciation, Depletion And Amortization $11.06M $10.23M
YoY Change 3.09% 1.09%
Cash From Operating Activities $7.474M $18.50M
YoY Change -48.03% 57.66%
INVESTING ACTIVITIES
Capital Expenditures $4.020M $5.480M
YoY Change -80.64% -153.93%
Acquisitions
YoY Change
Other Investing Activities $1.303M $1.590M
YoY Change -34.65% 107.3%
Cash From Investing Activities -$2.717M -$3.880M
YoY Change -85.52% -58.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.236M -14.15M
YoY Change -343.88% 584.24%
NET CHANGE
Cash From Operating Activities 7.474M 18.50M
Cash From Investing Activities -2.717M -3.880M
Cash From Financing Activities -5.236M -14.15M
Net Change In Cash -479.0K 470.0K
YoY Change -78.62% 72.79%
FREE CASH FLOW
Cash From Operating Activities $7.474M $18.50M
Capital Expenditures $4.020M $5.480M
Free Cash Flow $3.454M $13.02M
YoY Change -154.13% -40.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
dei Entity Central Index Key
EntityCentralIndexKey
0001537028
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3M
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36590
dei Entity Registrant Name
EntityRegistrantName
Independence Contract Drilling, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1653648
dei Entity Address Address Line1
EntityAddressAddressLine1
20475 State Highway 249
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77070
dei City Area Code
CityAreaCode
281
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14169942
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13698851
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14084850
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13613759
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
141000
dei Local Phone Number
LocalPhoneNumber
598-1230
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
ICD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14084850
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6044000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5326000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26874000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39775000
CY2023Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1877000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1508000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
325000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1854000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4736000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
36649000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
51670000
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
366263000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
376084000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3199000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1960000
CY2023Q3 us-gaap Assets
Assets
406111000
CY2022Q4 us-gaap Assets
Assets
429714000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1405000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2485000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
17275000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31946000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12128000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17608000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
30808000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
52039000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
156336000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
143223000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10869000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12266000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1642000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7474000
CY2023Q3 us-gaap Liabilities
Liabilities
199655000
CY2022Q4 us-gaap Liabilities
Liabilities
215002000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
136000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
621092000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
617606000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-410844000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-399097000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
85092
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
85092
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3933000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3933000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
206456000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
214712000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
406111000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
429714000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44164000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49147000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
164276000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126451000
CY2023Q3 us-gaap Direct Operating Costs
DirectOperatingCosts
27494000
CY2022Q3 us-gaap Direct Operating Costs
DirectOperatingCosts
31379000
us-gaap Direct Operating Costs
DirectOperatingCosts
98781000
us-gaap Direct Operating Costs
DirectOperatingCosts
87448000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6865000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7007000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18816000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17096000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10229000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10120000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
32488000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
29719000
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
250000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
250000
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1454000
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-433000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-539000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
665000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
43384000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
48939000
us-gaap Costs And Expenses
CostsAndExpenses
150874000
us-gaap Costs And Expenses
CostsAndExpenses
133598000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
780000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
208000
us-gaap Operating Income Loss
OperatingIncomeLoss
13402000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7147000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9222000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8098000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-26192000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-21005000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-46347000
icd Change In Fair Value Of Embedded Derivative Liability
ChangeInFairValueOfEmbeddedDerivativeLiability
4265000
icd Realized Gain On Extinguishment Of Derivative
RealizedGainOnExtinguishmentOfDerivative
10765000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8442000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7890000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12790000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-67999000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-844000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-696000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1044000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
783000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7598000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7194000
us-gaap Net Income Loss
NetIncomeLoss
-11746000
us-gaap Net Income Loss
NetIncomeLoss
-68782000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.36
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14071000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14071000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13590000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13590000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13992000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13992000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12836000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12836000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
214712000
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-385000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-34000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1374000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
215679000
CY2023Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-4000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1255000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4161000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
212769000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1285000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7598000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
206456000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
195229000
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-32000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3360000
CY2022Q1 icd Stock Issued During Period Value Restructuring
StockIssuedDuringPeriodValueRestructuring
9163000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
292000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-58796000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
149216000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-205000
CY2022Q2 icd Adjustments To Additional Paid In Capital Extinguishment Of Derivative
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivative
69232000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
528000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2791000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
215980000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-117000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1303000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7194000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
209972000
us-gaap Profit Loss
ProfitLoss
-11746000
us-gaap Profit Loss
ProfitLoss
-68782000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
32488000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
29719000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
250000
us-gaap Share Based Compensation
ShareBasedCompensation
4639000
us-gaap Share Based Compensation
ShareBasedCompensation
2976000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-539000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
665000
us-gaap Paid In Kind Interest
PaidInKindInterest
18202000
us-gaap Paid In Kind Interest
PaidInKindInterest
15859000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-46347000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
83000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
320000
icd Amortization Of Convertible Notes Issuance Costs And Debt Discount
AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount
5967000
icd Amortization Of Convertible Notes Issuance Costs And Debt Discount
AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount
4310000
icd Change In Fair Value Of Embedded Derivative Liability
ChangeInFairValueOfEmbeddedDerivativeLiability
4265000
icd Realized Gain On Extinguishment Of Derivative
RealizedGainOnExtinguishmentOfDerivative
10765000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1397000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
354000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1177000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
256000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-11724000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
12012000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
419000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
291000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1330000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2098000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9289000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
208000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53548000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14197000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36635000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22286000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3135000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2749000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19537000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
157500000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
10000000
icd Repayments Of Term Loan Facility
RepaymentsOfTermLoanFacility
139076000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
23540000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1576000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
30351000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
28000
icd Payments Of Merger Consideration
PaymentsOfMergerConsideration
2902000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-34000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3038000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
389000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2096000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3814000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19330000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8766000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
718000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3426000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5326000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4140000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6044000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7566000
us-gaap Interest Paid Net
InterestPaidNet
1940000
us-gaap Interest Paid Net
InterestPaidNet
4745000
us-gaap Income Taxes Paid
IncomeTaxesPaid
739000
icd Purchases Of Property Plant And Equipment In Accounts Payable
PurchasesOfPropertyPlantAndEquipmentInAccountsPayable
-11806000
icd Purchases Of Property Plant And Equipment In Accounts Payable
PurchasesOfPropertyPlantAndEquipmentInAccountsPayable
9015000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1482000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
3250000
icd Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets
FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets
324000
icd Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets
FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets
163000
icd Initial Embedded Derivative Liability Upon Issuance Of Convertible Notes
InitialEmbeddedDerivativeLiabilityUponIssuanceOfConvertibleNotes
75733000
icd Non Cash Or Part Non Cash Expenses Restructuring Fees
NonCashOrPartNonCashExpensesRestructuringFees
9163000
CY2022Q1 icd Market Price Of Oil
MarketPriceOfOil
123.64
CY2023Q4 icd Market Price Of Oil
MarketPriceOfOil
85.49
CY2022Q3 icd Market Price Of Oil
MarketPriceOfOil
9.85
CY2022Q4 icd Natural Gas Price
NaturalGasPrice
3.52
CY2023Q4 icd Natural Gas Price
NaturalGasPrice
2.65
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
500000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1700000
CY2022Q3 icd Capitalized Contract Cost Increase
CapitalizedContractCostIncrease
1000000.0
icd Capitalized Contract Cost Increase
CapitalizedContractCostIncrease
3100000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44164000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
49147000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
164276000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
126451000
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2023Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
26847000
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
39732000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
434000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1158000
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
131000
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
209000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1046000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
542000
CY2023Q3 icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
-524000
CY2022Q3 icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
1186000
icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
322000
icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
1227000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
397000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
37000
CY2023Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
200000
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
300000
CY2023Q3 icd Capitalized Contract Cost Increase
CapitalizedContractCostIncrease
0
icd Capitalized Contract Cost Increase
CapitalizedContractCostIncrease
1600000
CY2022Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
200000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
2800000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
298000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
193000
us-gaap Operating Lease Cost
OperatingLeaseCost
787000
us-gaap Operating Lease Cost
OperatingLeaseCost
580000
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1670000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1505000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5332000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
4170000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
140000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
157000
us-gaap Variable Lease Cost
VariableLeaseCost
451000
us-gaap Variable Lease Cost
VariableLeaseCost
413000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
264000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
464000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1470000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1109000
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
68000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
92000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
216000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
305000
CY2023Q3 icd Finance Lease Cost
FinanceLeaseCost
332000
CY2022Q3 icd Finance Lease Cost
FinanceLeaseCost
556000
icd Finance Lease Cost
FinanceLeaseCost
1686000
icd Finance Lease Cost
FinanceLeaseCost
1414000
CY2023Q3 us-gaap Lease Cost
LeaseCost
2440000
CY2022Q3 us-gaap Lease Cost
LeaseCost
2411000
us-gaap Lease Cost
LeaseCost
8256000
us-gaap Lease Cost
LeaseCost
6577000
us-gaap Operating Lease Payments
OperatingLeasePayments
674000
us-gaap Operating Lease Payments
OperatingLeasePayments
557000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
216000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
300000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2096000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3814000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2106000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
153000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1482000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
3250000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2450000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
976000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
992000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
751000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1564000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
373000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2556000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1124000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
6665000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
7307000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
2009000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1994000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
4656000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
5313000
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1405000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2485000
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1514000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1599000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
2919000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
4084000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0884
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1086
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0808
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0812
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
300000
CY2023Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
460000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1086000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1416000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
516000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
948000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
401000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
370000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
370000
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2023Q3 icd Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
285000
CY2023Q3 icd Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
0
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2958000
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3194000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
402000
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
275000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2556000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
2919000
CY2022Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
1900000
CY2022Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
2400000
CY2022Q2 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
69200000
CY2022Q2 icd Realized Gain On Extinguishment Of Derivative
RealizedGainOnExtinguishmentOfDerivative
10800000
CY2022Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y8M12D
CY2023Q1 icd Fair Value Liabilities Level Transfers Amount
FairValueLiabilitiesLevelTransfersAmount
0
CY2023Q2 icd Fair Value Liabilities Level Transfers Amount
FairValueLiabilitiesLevelTransfersAmount
0
CY2023Q3 icd Fair Value Liabilities Level Transfers Amount
FairValueLiabilitiesLevelTransfersAmount
0
CY2023Q1 icd Fair Value Assets Level Transfers Amount
FairValueAssetsLevelTransfersAmount
0
CY2023Q2 icd Fair Value Assets Level Transfers Amount
FairValueAssetsLevelTransfersAmount
0
CY2023Q3 icd Fair Value Assets Level Transfers Amount
FairValueAssetsLevelTransfersAmount
0
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
819000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3796000
CY2023Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
195000
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
283000
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
840000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
657000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1854000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4736000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4841000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6908000
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
942000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
3002000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
434000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1003000
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
2231000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3621000
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
27000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
101000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
992000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
751000
CY2023Q3 icd Accrued Liabilities Time Based Cash Settled Stock Appreciation Rights
AccruedLiabilitiesTimeBasedCashSettledStockAppreciationRights
2380000
CY2022Q4 icd Accrued Liabilities Time Based Cash Settled Stock Appreciation Rights
AccruedLiabilitiesTimeBasedCashSettledStockAppreciationRights
1826000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
281000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
396000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12128000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17608000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
2919000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
4084000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
192128000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
186061000
CY2023Q3 icd Convertible Notes Issuance Costs And Debt Discount
ConvertibleNotesIssuanceCostsAndDebtDiscount
34387000
CY2022Q4 icd Convertible Notes Issuance Costs And Debt Discount
ConvertibleNotesIssuanceCostsAndDebtDiscount
40353000
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1405000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2485000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
156336000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
143223000
CY2023Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
5000000.0
CY2023Q3 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
5000000.0
CY2023Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
5000000.0
CY2023Q2 icd Repayment Of Accrued Interest On Notes
RepaymentOfAccruedInterestOnNotes
200000
CY2023Q3 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
5000000.0
CY2023Q3 icd Repayment Of Accrued Interest On Notes
RepaymentOfAccruedInterestOnNotes
400000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1786000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1773000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4639000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2976000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
33332
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
14084850
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
85092
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q1 icd Number Of Directors
NumberOfDirectors
6
CY2022Q3 icd Number Of Directors
NumberOfDirectors
7
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-7598000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7194000
us-gaap Net Income Loss
NetIncomeLoss
-11746000
us-gaap Net Income Loss
NetIncomeLoss
-68782000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.84
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.36
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14071000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13590000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13992000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12836000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14071000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13590000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13992000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12836000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39254000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37971000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39135000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28209000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.100
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.082
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.088
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.012
CY2023Q3 us-gaap Purchase Obligation
PurchaseObligation
2300000
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
78900000
CY2022Q1 icd Investor S Rights Agreement Number Of Directors Who Can Be Nominated
InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated
1
CY2022Q1 icd Investors Rights Agreement Principal Amount
InvestorsRightsAgreementPrincipalAmount
25000000.0
CY2022Q1 icd Investor S Rights Agreement Number Of Directors Who Can Be Nominated
InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated
1
CY2022Q1 icd Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director
NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector
2
CY2022Q1 icd Number Of Additional Representative To Be Appointed As Individual Director
NumberOfAdditionalRepresentativeToBeAppointedAsIndividualDirector
1
CY2022Q1 icd Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director
NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector
2

Files In Submission

Name View Source Status
icd-20230930_lab.xml Edgar Link unprocessable
icd-20230930_pre.xml Edgar Link unprocessable
0001537028-23-000041-index-headers.html Edgar Link pending
0001537028-23-000041-index.html Edgar Link pending
0001537028-23-000041.txt Edgar Link pending
0001537028-23-000041-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
icd-20230930.xsd Edgar Link pending
icd-20230930x10q.htm Edgar Link pending
icd-20230930xex31d1.htm Edgar Link pending
icd-20230930xex31d2.htm Edgar Link pending
icd-20230930xex32d1.htm Edgar Link pending
icd-20230930xex32d2.htm Edgar Link pending
icd-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
icd-20230930_def.xml Edgar Link unprocessable
icd-20230930x10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending